Lithium Ion

Lithium Ion

SCHEMBL31705265

O=C([O-])c1cc(C2=CCN(C3COC3)C2)ccn1.O=C([O-])c1cc(C2=CCN(C3COC3)C2)ccn1.[Li+].[Li+]

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ TBK1 Q9UHD2 1/20 0.35
▸ OPRM1 P35372 5/20 0.34
▸ HDAC2 Q92769 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL31704782 1.00 TBK1 (0.35) TBK1OPRM1HDAC2ALDH1A1SMN1; SMN2
Lithium Ion SCHEMBL31704957 0.89 OPRM1 (0.34) OPRM1HDAC2
Lithium Ion SCHEMBL31704679 0.89 OPRM1 (0.34) OPRM1HDAC2
Lithium Ion SCHEMBL31705586 0.88 ALDH1A1 (0.38) OPRM1ALDH1A1SMN1; SMN2
Lithium Ion SCHEMBL31706302 0.88 ALDH1A1 (0.38) OPRM1ALDH1A1SMN1; SMN2
SCHEMBL31704665 0.84 TBK1 (0.38) TBK1OPRM1HDAC2ALDH1A1
SCHEMBL31706770 0.76 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2
Lithium Ion SCHEMBL31706495 0.72 TLR9 (0.43) OPRM1
Lithium Ion SCHEMBL31705410 0.72 TLR9 (0.43) OPRM1
Lithium Ion SCHEMBL31704516 0.72 KIT (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215110-A1 NEW AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS SOS1 INHIBITORS LES LABORATOIRES SERVIER (FR) 2025-10-16 — — WO disclosed
Send feedback